Gene: TBC1D7-LOC100130357
Gene Summary: This locus represents naturally occurring readthrough transcription between the neighboring TBC1D7 (TBC1 domain family member 7) gene and downstream uncharacterized LOC100130357 on chromosome 6. Readthrough transcripts may encode the same protein as TBC1 domain family member 7 or may be candidates for nonsense-mediated mRNA decay (NMD). [provided by RefSeq, Jan 2016]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO09111 | TBC1D7-LOC100130357 Knockout cell line (HeLa) | Human | TBC1D7-LOC100130357 | 1:3~1:6 | Negative | Online Inquiry |
KO09112 | TBC1D7-LOC100130357 Knockout cell line (HCT 116) | Human | TBC1D7-LOC100130357 | 1:2~1:4 | Negative | Online Inquiry |
KO09113 | TBC1D7-LOC100130357 Knockout cell line (HEK293) | Human | TBC1D7-LOC100130357 | 1:3~1:6 | Negative | Online Inquiry |
KO09114 | TBC1D7-LOC100130357 Knockout cell line (A549) | Human | TBC1D7-LOC100130357 | 1:3~1:4 | Negative | Online Inquiry |
TBC1D7-LOC100130357 Gene Knockout Cell Lines are genetically modified cell lines designed to facilitate the study of the TBC1D7 gene and its associated biological functions in a controlled environment. These knockout cell lines have been engineered to inactivate the TBC1D7 gene, which plays a crucial role in regulating cellular processes such as protein trafficking and signaling pathways involved in cell proliferation and differentiation. By eliminating the TBC1D7 gene, researchers can effectively investigate the consequences of its loss of function, uncovering insights into associated phenotypic changes, cellular mechanisms, and the potential involvement of this gene in various diseases, including cancer.
The primary mechanism behind these knockout cell lines is their use of CRISPR/Cas9 technology, a powerful genome-editing tool that enables precise disruptions at specific genomic loci. This approach allows for a straightforward examination of gene function, providing invaluable data on how TBC1D7 interacts with other cellular components and affects overall cellular behavior. In research and clinical settings, these cell lines are essential for elucidating the role of TBC1D7 in pathophysiological contexts, such as metabolic disorders and oncogenesis.
Compared to traditional methods of gene manipulation, TBC1D7-LOC100130357 Gene Knockout Cell Lines offer several advantages. They enable high specificity in gene editing, reduced off-target effects, and can be generated quickly, allowing researchers to accelerate their studies. Additionally, these cell lines come with thorough validation, ensuring reliability and reproducibility, which is critical in scientific experiments.
For researchers and clinicians eager to explore the intricacies of gene functions and their contributions to disease mechanisms, TBC1D7-LOC100130357 Gene Knockout Cell Lines represent a valuable tool. By utilizing these specialized cell lines, users can push the boundaries of their research, translating into potential therapeutic innovations and enhanced understanding of gene-related pathologies. As a company committed to advancing scientific research, we ensure that our products, including the TBC1D7-LOC100130357 Gene Knockout Cell Lines, reflect the highest standards of quality and expertise in biological products.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.